 Chicago Tribune | Abbott christens new pharma company AbbVie PMLiVE ... gonadotropin-releasing hormone (GnRH) antagonist elagolix, partnered with Neurocrine Biosciences and in testing for endometriosis, as well as bardoxolone for chronic kidney disease, cancer drug elotuzumab and daclizumab for multiple sclerosis. Why Abbott Labs Is Only Good For Dividends |
